This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Well Characterized Biologics & Biological Assays
Well Characterized Biologics & Biological Assays is now part of BioProcess International
September 23-26, 2024Hynes Convention Center in Boston, USA

Bryan Hassell, PhD
Founder / Chief Technology Officer at Nirrin Technologies


Dr. Bryan Hassell is the co-founder and Chief Technology Officer of Nirrin Technologies. Prior to Nirrin, he worked as a Principal Investigator for the U.S. Department of Defense, and has held a position with Anzu Partners, a venture capital/PE firm concentrating on industrial breakthrough technologies. Bryan received his M.S and Ph.D. in Applied Physics from Harvard University and in his spare time enjoys surfing, skateboarding and playing music.

Agenda Sessions

  • Tune into your Formulation: Rapid at/in-line Accurate Quantitation of Excipients and Protein Titer using High Precision Tunable Laser Spectroscopy (HPTLS™)